Coronary interventions

Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial

EuroIntervention 2016;11:1372-1379 published online ahead of print November 2014. DOI: 10.4244/EIJY14M11_02

Sebastian Kufner1*, MD; Robert A. Byrne1, MB, BCh, PhD; Marco Valeskini1; Stefanie Schulz1, MD; Tareq Ibrahim2, MD; Petra Hoppmann2, MD; Simon Schneider2, MD; Karl-Ludwig Laugwitz2,3, MD; Heribert Schunkert1,3, MD; Adnan Kastrati1,3, MD; for the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST 4) Investigators

1. Deutsches Herzzentrum München, Technische Universität, Munich, Germany; 2. 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Munich, Germany; 3. DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Allianc

Aims: Both biodegradable polymer sirolimus-eluting stents and permanent polymer everolimus-eluting stents offer potential for enhanced late outcomes in comparison with earlier-generation

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

biodegradable polymerclinical researcheverolimuslong-term outcomepermanent polymersirolimus

Coronary interventionsStents and scaffoldsTools, devices and techniques

Share on Facebook Share on Twitter Share on Linkedin

Latest news

NEW ISSUE

State-of-the-Art on MINOCA; clopidogrel monotherapy; clinical presentation and bleeding risk after PCI; POT technique; LAAO; and more…

December 3, 2021

STATE OF THE ART

Myocardial infarction with non-obstructive coronary artery disease

December 3, 2021

NEWS

EuroIntervention is now on Instagram

November 29, 2021

AHEAD OF PRINT

Long-term impact of OCT-assessed suboptimal stent deployment

Francesco Prati et al.

November 25, 2021

EDITORIAL

Is clopidogrel as the P2Y12 inhibitor a wise choice for long-term monotherapy in patients undergoing stenting?

December 3, 2021

EDITORIAL

Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?

Josep Rodés-Cabau et al.

November 23, 2021

CONSENSUS

Guidelines, consensus & position papers

consult the most recent published guidelines, consensus and position papers